Skip to main content

Animations

MJFF Publications

4031 - 4040 of 8673 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2021
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: The Impact of the COVID‐19 Pandemic on Care Partners of People with Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mdc3.13678
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Quantified Striatal Dopaminergic Denervation as Predictor for Motor Outcomes in Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mdc3.13726
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Predictors of Future Deep Brain Stimulation Surgery in de novo Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mdc3.13747
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Insomnia symptom subtypes and manifestations of prodromal neurodegeneration: a population-based study in the Canadian Longitudinal Study on Aging
    Journal Name: Journal of Clinical Sleep Medicine
    Publisher: American Academy of Sleep Medicine (AASM)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.5664/jcsm.9562
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma
    Journal Name: Molecular Cancer Therapeutics
    Publisher: American Association for Cancer Research (AACR)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1158/1535-7163.mct-21-0836
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Unveiling the B cell receptor structure
    Journal Name: Science
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/science.add8065
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites
    Journal Name: Science
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/science.abm3233
    Citation Count: 165
  • Summary Details
    OPEN
    Title: A NAC domain mutation (E83Q) unlocks the pathogenicity of human alpha-synuclein and recapitulates its pathological diversity
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/sciadv.abn0044
    Citation Count: 35
  • Summary Details
    RESTRICTED
    Title: Toward preventing Parkinson’s disease
    Journal Name: Science
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1126/science.add7162
    Citation Count: 15
  • Summary Details
    OPEN
    Title: GPNMB confers risk for Parkinson’s disease through interaction with α-synuclein
    Journal Name: Science
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/science.abk0637
    Citation Count: 113
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.